Business Case

Developed comprehensive approach to navigate international reimbursement for a GTx while managing channel-specific pricing considerations

Our client, a large biotech was gearing up to launch a GTx for a rare disease and sought assistance developing appropriate U.S. and ex-U.S. pricing strategies. LSC devised a strategy to pinpoint the value proposition the therapy held for payers, outlining a spectrum of reimbursement scenarios to help our client navigate the ever-evolving dynamics of payers and reimbursement, ultimately developing a variety of potential value-based contracts for consideration. The comprehensive approach provided our client with insights into payer preferences, possible contract structures and, specifically, for the U.S., the pricing ramifications across different channels and equipping them for a strategic market entry.